期刊文献+

开展以遗传学类型分类骨髓增生异常综合征的针对性治疗研究 被引量:11

Treatment focused on myelodysplastic syndromes based on cytogenetic categories
原文传递
导出
摘要 骨髓增生异常综合征(MDS)是一组起源于造血干(祖)细胞的克隆性异质性疾患,其异质性不仅表现在外周血和骨髓象上,也表现在细胞遗传学、病程、转归和对治疗的反应上.MDS遗传学分型应是一种能反映疾病本质的分型方法 .国内应开展MDS遗传学分型的生物学特征研究,以MDS遗传学分型指导MDS的临床分型治疗,提高其临床疗效. Myelodysplastic syndromes (MDS) are heterogeneous clonal stem cell disorders characterised not only by peripheral cytopenia and bone marrow hyperplasia but also by karyotype. The course of disease, clinical outcome and response to treatment. Cytogenetic categories is a pattern typing the intrinsical features of MDS. It is suggested here that investigating biological characters and group treatment in MDS based on cytogenetic categories may enhance the therapeutic effect and bring benefit to MDS patients.
作者 麻柔 胡晓梅
出处 《白血病.淋巴瘤》 CAS 2010年第5期262-264,共3页 Journal of Leukemia & Lymphoma
关键词 骨髓增生异常综合征 遗传学分型 分型治疗 Myelodysplastic syndromes Cytogenetic categories Group treatment
  • 相关文献

参考文献19

  • 1肖志坚.循证医学指导下的血液病规范化诊治[J].中国实用内科杂志,2007,27(14):1091-1094. 被引量:18
  • 2郝洪波,肖志坚.不典型骨髓增生异常综合征的诊断[J].白血病.淋巴瘤,2005,14(2):121-123. 被引量:3
  • 3Vardiman JW,Harris NL,Brunning RD.The World Health Organization (WHO) classification of the myeloid neoplasms.Blood,2002,100:2292-2302.
  • 4Vardiman JW,Thiele J,Arber DA,et al.The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia:rationale and important changes.Blood,2009,114:947-951.
  • 5Bernasconi P,Klersy C,Boni M,et al.World Heath Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.Br J Hematol,2007,137:193-205.
  • 6Ol'shanskaia IuV,Domracheva EV,Udovichenko AI,et al.Chromosomal aberrations in myelodysplastic syndrome.Ter Arkh,2005,77:27-33.
  • 7Haase D,Germing U,Schanz J,et al.New insights into the prognostic impact of the karotype in MDS and correlation with subtypes:evidence from a core dataset 2124 patients.Blood,2007,110:4385-4395.
  • 8Pedersen-Bjergaard J,Andersen MT,Mette K.Andersen:Genetic Pathways in the Pathogenesis of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia.American Society of Hematology,2007,392-397.
  • 9肖志坚.骨髓增生异常综合征:现况与问题[J].白血病.淋巴瘤,2005,14(4):193-196. 被引量:31
  • 10邱镜滢,张艳,陆道培,赖悦云,何琦,师岩.骨髓增生异常综合征中的亚急性髓性白血病临床与细胞遗传学研究[J].中华内科杂志,2005,44(6):407-410. 被引量:4

二级参考文献70

  • 1肖志坚.骨髓增生异常综合征:现况与问题[J].白血病.淋巴瘤,2005,14(4):193-196. 被引量:31
  • 2Cachia P G, Taylor C, Thompson P W. Nondysplastic myelodysplasia [J]. Leukemia,1994, 8(4):677-681.
  • 3Anttila P, Ihalainen J, Salo A, et al. Idiopathic macrocytic anaemia in the aged:molecular and cytogenetic findings [J]. Br J Haematol, 1995, 90(4):797-803.
  • 4Steensma D P, Dewald G W, Hodnefield J M,et al. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia[J]. Leuk Res,2003, 27(3):235 -242.
  • 5Bain B J. The bone marrow aspirate of healthy subjects[J]. Br J Haematol, 1996, 94(1):206-209.
  • 6Ramos F, Fernandez-Ferro S, Suarez D, et al.myelodysplastic syndrome: a search for minimal diagnostic criteria[J]. Leuk Res, 1999, 23(3):283 -290.
  • 7Hasle H, Niemeyer C M, Chessells J M, et al.A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases[J]. Leukemia, 2003, 17(2):277-282.
  • 8Tuzuner N, Cox C, RoweJ M, et al. Hypocellular myelodysplastic syndromes (MDS): newproposals[J]. Br J Haematol, 1995,91(3):612-617.
  • 9Tuzuner N, Cox C, Rowe J M, et al. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction[J]. Leuk Res,1994, 18(8):559-564.
  • 10Maschek H, Kaloutsi V, Rodriguez-Kaiser M, et al. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis[J]. Ann Hematol, 1993, 66(3):117-122.

共引文献96

同被引文献151

引证文献11

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部